Christopher Giancarlo, acting chairman of the U.S. Commodity Futures Trading Commission, announced an innovation lab this month designed to further the future of fintech. The initiative, which draws on the idea of giving fintech companies in the commodities and derivatives markets greater access to the commission, is intended to bring “21st century regulation for today’s capital markets.” But in a speech delivered May 17, Giancarlo stopped short of referring to the initiative, LabCFTC, as a regulatory sandbox — an environment in which companies can test new products and business models without worrying about regulatory consequences — because so far there is no intention of providing any regulatory relief for participating companies.
The announcement of LabCFTC, along with the Office of the Comptroller of the Currency’s proposed fintech charter, released in March, show that regulators are looking for ways to support the industry. But all of these developments combined beg the question: Will the U.S. at any point introduce a regulatory sandbox like those seen in the United Kingdom or Singapore? While many fintechs, particularly early stage startups, would likely welcome the regulatory exemptions sandboxes provide while developing their products, many lawyers in the industry are skeptical that a sandbox will happen in the U.S. because it has some unique challenges working against it.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]